The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.

Medically reviewed by Kathleen Daly, MD Postpartum depression (PPD), sometimes called perinatal depression, is a type of ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

According to recent studies, postpartum depression affects approximately one in seven women, though rates may be even higher ...